Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Translational Development Acquisition (TDAC) Cash from Financing Activities (2024 - 2026)

Translational Development Acquisition's Cash from Financing Activities history spans 3 years, with the latest figure at $300000.0 for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities changed N/A to $300000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $175.8 million, a N/A change, with the full-year FY2025 number at $200000.0, down 99.89% from a year prior.
  • Cash from Financing Activities came in at $300000.0 for Q1 2026, up from $100000.0 in the prior quarter.
  • The five-year high for Cash from Financing Activities was $175.3 million in Q4 2024, with the low at $100000.0 in Q4 2025.
  • Historically, Cash from Financing Activities has averaged $44.0 million across 3 years, with a median of $246250.0 in 2024.
  • Peak annual rise in Cash from Financing Activities hit 99.94% in 2025, while the deepest fall reached 99.94% in 2025.
  • Year by year, Cash from Financing Activities stood at $175.3 million in 2024, then crashed by 99.94% to $100000.0 in 2025, then soared by 200.0% to $300000.0 in 2026.
  • Business Quant data shows Cash from Financing Activities for TDAC at $300000.0 in Q1 2026, $100000.0 in Q4 2025, and $175.3 million in Q4 2024.